Direct and Indirect Effectiveness of Influenza Vaccination Delivered to Children at School Preceding an Epidemic Caused by 3 New Influenza Virus Variants

被引:70
作者
Glezen, W. Paul [1 ,2 ]
Gaglani, Manjusha J. [3 ,4 ]
Kozinetz, Claudia A. [2 ]
Piedra, Pedro A. [1 ,2 ]
机构
[1] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[3] Scott & White Mem Hosp & Clin, Dept Pediat, Sect Pediat Infect Dis, Temple, TX 76508 USA
[4] Texas A&M Univ, Coll Med, Temple, TX 76508 USA
基金
美国国家卫生研究院;
关键词
UNITED-STATES; CAIV-T; TRIVALENT; EFFICACY; IMMUNIZATION; INTRANASAL; PROTECTION; SAFETY; H1N1;
D O I
10.1086/657089
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Influenza is an uncontrolled epidemic disease that is vaccine preventable. New recommendations for universal immunization present a challenge to the implementation of vaccine delivery. This field trial examines the effectiveness of school-based clinics for vaccine delivery before an epidemic caused by 3 new influenza virus variants not contained in the vaccine. Methods. Live attenuated influenza vaccine (LAIV) was offered to eligible children in elementary schools of eastern Bell County, Texas. Age-specific rates of medically attended acute respiratory illness for health plan members at the intervention site were compared with those for members at comparison sites during the epidemic, defined by viral surveillance at all sites. Results. Almost 48% of children in elementary schools were vaccinated. Significant herd protection attributed to LAIV was detected for all age groups except 12-17-year-old students, who were not offered free vaccine. Approximately 2500 medical encounters were prevented at the intervention site. Inactivated vaccine provided marginal protection against the epidemic viruses. Conclusions. LAIV delivered to elementary-school children before an epidemic caused by 3 new variant influenza viruses generated significant cross-protection for the recipients and indirect (herd) protection for the community.
引用
收藏
页码:1626 / 1633
页数:8
相关论文
共 31 条
[1]   Duration of protection provided by live attenuated influenza vaccine in children [J].
Ambrose, Christopher S. ;
Yi, Tingting ;
Walker, Robert E. ;
Connor, Edward M. .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2008, 27 (08) :744-748
[2]  
Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P453
[3]  
[Anonymous], SEMIN PEDIAT INFECT
[4]   Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections [J].
Ashkenazi, Shai ;
Vertruyen, Andre ;
Aristegui, Javier ;
Esposito, Susanna ;
McKeith, David Douglas ;
Klemola, Timo ;
Biolek, Jiri ;
Kuehr, Joachim ;
Bujnowski, Tadeusz ;
Desgrandchamps, Daniel ;
Cheng, Sheau-Mei ;
Skinner, Jonathan ;
Gruber, William C. ;
Forrest, Bruce D. .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (10) :870-879
[5]   Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine [J].
Belshe, RB ;
Gruber, WC ;
Mendelman, PM ;
Cho, I ;
Reisinger, K ;
Block, SL ;
Wittes, J ;
Iacuzio, D ;
Piedra, P ;
Treanor, J ;
King, J ;
Kotloff, K ;
Bernstein, DI ;
Hayden, FG ;
Zangwill, K ;
Yan, LH ;
Wolff, M .
JOURNAL OF PEDIATRICS, 2000, 136 (02) :168-175
[6]   Live attenuated versus inactivated influenza vaccine in infants and young children [J].
Belshe, Robert B. ;
Edwards, Kathryn M. ;
Vesikari, Timo ;
Black, Steven V. ;
Walker, Robert E. ;
Hultquist, Micki ;
Kemble, George ;
Connor, Edward M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (07) :685-696
[7]   Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity [J].
Belshe, Robert B. ;
Coelingh, Kathleen ;
Ambrose, Christopher S. ;
Woo, Jennifer C. ;
Wu, Xionghua .
VACCINE, 2010, 28 (09) :2149-2156
[8]   Influenza-associated deaths among children in the United States, 2003-2004 [J].
Bhat, N ;
Wright, JG ;
Broder, KR ;
Murray, EL ;
Greenberg, ME ;
Glover, MJ ;
Likos, AM ;
Posey, DL ;
Klimov, A ;
Lindstrom, SE ;
Balish, A ;
Medina, MJ ;
Wallis, TR ;
Guarner, J ;
Paddock, CD ;
Shieh, WJ ;
Zaki, SR ;
Sejvar, JJ ;
Shay, DK ;
Harper, SA ;
Cox, NJ ;
Fukuda, K ;
Uyeki, TM .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (24) :2559-2567
[9]  
Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P941
[10]   Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma [J].
Fleming, Douglas M. ;
Crovari, Pietro ;
Wahn, Ulrich ;
Klemola, Timo ;
Schlesinger, Yechiel ;
Langussis, Alexangros ;
Oymar, Knut ;
Garcia, Maria Luz ;
Krygier, Alain ;
Costa, Herculano ;
Heininger, Ulrich ;
Pregaldien, Jean-Louis ;
Cheng, Sheau-Mei ;
Skinner, Jonathan ;
Razmpour, Ahmad ;
Saville, Melanie ;
Gruber, William C. ;
Forrest, Bruce .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (10) :860-869